For these reasons, several drugs, such as metformin, SGLT-2 inhibitors, TZD, and GLP-1 agonists, are used in the treatment of T2DM have been assessed for improving fat metabolism in patients with NAFLD. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.